Still Early Dwaan!!Canopy is moving into the US market, of which is still in a stage completion...Canopy and Constellation have been on top of this industry and it's major potential going forward. The R&D and lessons learned has generated what is going to be a leading global industry, right now if one does their DD it is clearer every day there is significant upside for healthcare bennefit and without the risks of the attempts to generate the same end results from the chemical world.
There will be much better to come for the industry and health care, as well as market share increases ROI will realize handsome rewards for those that own. The heavy scrutiny of the product will only strenthen it's acceptance and usage.The 'plant' is an asset in many areas now and only improve from here as R&D refines the scope of this potential and it is made available to the public and the medical profession. Everybody needs to do their DD and buy, sell or hold. JMHO...Opt
https://stockhouse.com/companies/bullboard/t.weed/canopy-growth-corporation?threadid=35396784